Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: PJX9GH268R

Structure

InChI Key ZRYMMWAJAFUANM-INIZCTEOSA-N
Smile Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O
InChI
InChI=1S/C32H30F2N4O4/c1-15-17(7-6-10-24(15)38-30(40)19-8-5-9-21(33)28(19)37(4)31(38)41)25-22(34)14-20(29(35)39)27-26(25)18-12-11-16(32(2,3)42)13-23(18)36-27/h5-10,14,16,36,42H,11-13H2,1-4H3,(H2,35,39)/t16-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C32H30F2N4O4
Molecular Weight 572.61
AlogP 4.4
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 4.0
Polar Surface Area 123.11
Molecular species NEUTRAL
Aromatic Rings 5.0
Heavy Atoms 42.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Tyrosine-protein kinase BTK inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Arthritis, Rheumatoid 2 D001172 ClinicalTrials
Osteoarthritis 1 D010003 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 1643368-58-4
ChEMBL CHEMBL3900554
DrugBank DB15291
FDA SRS PJX9GH268R
Guide to Pharmacology 9857
PDB 73T
PubChem 86582336
SureChEMBL SCHEMBL16319712
ZINC ZINC000222995022